KPIs & Operating Metrics(New)
Growth Metrics

Colgate Palmolive (CL) Cash & Equivalents (2016 - 2025)

Colgate Palmolive (CL) has 17 years of Cash & Equivalents data on record, last reported at $1.3 billion in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 17.52% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $1.3 billion, up 17.52%, while the annual FY2025 figure was $1.3 billion, 17.52% up from the prior year.
  • Cash & Equivalents reached $1.3 billion in Q4 2025 per CL's latest filing, up from $1.3 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.3 billion in Q4 2025 and bottomed at $775.0 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $1.0 billion, with a median of $962.0 million recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: decreased 11.86% in 2022, then surged 35.53% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $832.0 million in 2021, then dropped by 6.85% to $775.0 million in 2022, then rose by 24.65% to $966.0 million in 2023, then grew by 13.46% to $1.1 billion in 2024, then grew by 17.52% to $1.3 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $1.3 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.2 billion in Q2 2025.